Zenotech Laboratories Limited (BOM:532039)

Zenotech Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	418.1	389.76	367.62	383.53	324.94	193.73
Other Revenue	1.23	1.23	0.47	6.56	4.53	0.63
Revenue	419.33	390.98	368.09	390.09	329.47	194.36
Revenue Growth (YoY)	16.48%	6.22%	-5.64%	18.40%	69.51%	-25.07%
Cost of Revenue	39.11	43.24	30.89	29.34	30.48	14.76
Gross Profit	380.22	347.75	337.2	360.75	298.98	179.61
Selling, General & Admin	146.16	124	94.82	78.99	71.18	65.12
Other Operating Expenses	97.8	80.55	69.29	68.15	48.64	50.06
Operating Expenses	314.78	274.14	234.97	218.87	189.56	179.74
Operating Income	65.44	73.61	102.23	141.88	109.43	-0.13
Interest Expense	-	-	-	-1.12	-12.15	-15.48
Interest & Investment Income	14.09	14.09	9.45	3.69	0.99	0.55
Currency Exchange Gain (Loss)	-0.18	-0.18	0.05	-0.01	-0.03	-
Other Non Operating Income (Expenses)	6.57	-	-	-	-	-
EBT Excluding Unusual Items	85.92	87.52	111.74	144.44	98.23	-15.06
Gain (Loss) on Sale of Assets	-	-	-0.44	0.39	-	-
Other Unusual Items	-2.81	19.4	0.12	0.2	0.78	2.91
Pretax Income	83.11	106.92	111.41	145.02	99.01	-12.15
Income Tax Expense	49.5	50.79	28.43	29.17	-122.75	-
Net Income	33.62	56.13	82.99	115.85	221.76	-12.15
Net Income to Common	33.62	56.13	82.99	115.85	221.76	-12.15
Net Income Growth	-32.62%	-32.36%	-28.37%	-47.76%	-	-
Shares Outstanding (Basic)	61	61	61	61	61	61
Shares Outstanding (Diluted)	61	61	61	61	61	61
Shares Change (YoY)	0.35%	-	-	-	-	-
EPS (Basic)	0.55	0.92	1.36	1.90	3.63	-0.20
EPS (Diluted)	0.55	0.92	1.36	1.90	3.63	-0.20
EPS Growth	-32.86%	-32.36%	-28.37%	-47.71%	-	-
Free Cash Flow	-	56.25	75.89	144.33	157.3	8.3
Free Cash Flow Per Share	-	0.92	1.24	2.37	2.58	0.14
Gross Margin	90.67%	88.94%	91.61%	92.48%	90.75%	92.41%
Operating Margin	15.61%	18.83%	27.77%	36.37%	33.21%	-0.07%
Profit Margin	8.02%	14.36%	22.55%	29.70%	67.31%	-6.25%
Free Cash Flow Margin	-	14.39%	20.62%	37.00%	47.74%	4.27%
EBITDA	134.1	143.21	173.08	213.61	179.16	64.43
EBITDA Margin	31.98%	36.63%	47.02%	54.76%	54.38%	33.15%
D&A For EBITDA	68.66	69.6	70.85	71.73	69.74	64.56
EBIT	65.44	73.61	102.23	141.88	109.43	-0.13
EBIT Margin	15.61%	18.83%	27.77%	36.37%	33.21%	-0.07%
Effective Tax Rate	59.55%	47.50%	25.52%	20.11%	-	-
Revenue as Reported	480.7	445.96	418.37	435.08	371.94	228.54
Advertising Expenses	-	0.22	0.18	0.23	0.23	0.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.